Drug Enforcement D-1667-2012

CGMP Deviations: tubing used for filling may interact with the nasal formulation of this product.

Status

Terminated

Classification

Class III

Report Date

September 5, 2012

Termination Date

September 18, 2012

Product Information

Product description
Azelastine HCl Nasal Solution, 0.1 %, 137 mcg/spray, 30 mL bottle (200 Metered Sprays), Rx only, Mfg by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, NDC 60505-0833-5.
Product quantity
963,407 bottles
Reason for recall
CGMP Deviations: tubing used for filling may interact with the nasal formulation of this product.
Recall initiation reason
Initial firm notification
Letter
Distribution pattern
Nationwide and Puerto Rico

Location & Firm

Recalling firm
Apotex Corp.
Address
2400 N Commerce Pkwy Ste 400, N/A

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date

Codes & Dates

Recall number
D-1667-2012
Event ID
62930
Recall initiation date
June 15, 2011
Center classification date
August 29, 2012
Code info
Lot #: JK9130, JM0925, Exp 05/12; JN6514, Exp 07/12; JN1125, JN1127, Exp 08/12; JR5780, JR5782, Exp 12/12.
More code info